Kite Pharma

Kite Pharma, Inc. Focuses on Cell Therapy — Using Genetically Modified Immune Cells to Treat Tumors — Believes This Could Potentially Transform Cancer Treatment.Through our dedicated efforts and significant industry and academic partnerships, we have been able to advance our industry-leading Chimeric Antigen Receptor (CAR) and T Cell Receptor (TCR) product candidate pipeline to treat both hematologic cancers and solid tumors.